C
ABBV icon

Croban’s AbbVie ABBV Stock Holding History

Croban’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.5M Buy
6,905
+47
+0.7% +$10.4K 0.71% 39
2025
Q4 		$1.57M Buy
6,858
+74
+1% +$16.9K 0.76% 35
2025
Q3 		$1.57M Sell
6,784
-88
-1% -$17.9K 1.05% 35
2025
Q2 		$1.28M Buy
6,872
+8
+0.1% +$1.49K 1.09% 37
2025
Q1 		$1.44M Sell
6,864
-220
-3% -$42.8K 1.32% 22
2024
Q4 		$1.26M Buy
+7,084
New +$1.3M 1.24% 27
2023
Q4 		$1.26M Buy
+7,084
New +$1.03M 1.25% 27

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Croban's ABBV Position: Q1 2026 in Review

Croban increased its AbbVie (ABBV) stake by 0.69% in Q1 2026, buying an estimated $10.4K and bringing the position to 6,905 shares worth $1.5M. The position accounts for 0.71% of the portfolio, ranked #39.

Croban first reported a position in ABBV in Q4 2023 and has held it in 7 quarters since. The position peaked at $1.57M in Q3 2025. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Croban held 6,905 shares of AbbVie worth $1.5M as of Q1 2026.
  • Croban bought 47 AbbVie shares in Q1 2026, an estimated $10.4K.
  • AbbVie made up 0.71% of Croban's portfolio in Q1 2026, its #39 holding.
  • Croban first reported a position in AbbVie in Q4 2023 and has held it in 7 quarters since.
  • Croban's AbbVie position peaked at $1.57M in Q3 2025.
  • 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Croban's 13F filing for Q1 2026, filed 13 May 2026.